Epigenetics in drug discovery have recently drawn a lot of attention and there are increasing number of applications as reflected in the growing number publications and citations on this subject. This is because epigenetic dysfunction is widely implicated in several human diseases, including cancer, neurodegenerative and parasitic diseases. Epigenetic broadly involves covalent changes on the building blocks of chromatins called nucleosomes. The reactions involved include methylation, acetylation, phosphorylation, ubiquination and reverse reactions of those. Natural products are regaining attention as sources of lead compounds that can be used as a starting point of drug or epigenetic probe discovery. Natural products have documented large structural diversity with unique and complex scaffolds with promising activity and selectivity profile with epigenetic targets.
In this special collection of articles, we focus on natural products and natural product mimics and their derivatives that play modulatory or inhibitory roles in the epigenome. While current reviews mostly lay emphasis on naturally occurring epigenetic inhibitors and modulators of human disease targets, this series also looks at the epigenome of microbes and plants, which host the biosynthesis processes for making secondary metabolites.
Submissions (Editorials, Reviews, Concepts, Notes, Perspectives, Original Research, Book Reviews, etc.) are welcome in (but not limited to) the following topics:
• Natural remedies and pharmacogenomics of age-related and neurodegenerative disorders
• Implications of compounds of natural origin in disease-associated epigenetic mechanisms.
• Chemoinformatics exploration of the chemical space and target space of natural products with epigenetic functions.
• Bromodomain inhibitors of natural origin.
• A (re)classification of sirtuins and histone deacetylases based on current knowledge.
• Epigenetics in plant and marine life forms, fungal and microbial biosynthesis.
• Epigenetics and network pharmacology associated with treatment with natural remedies.
• Protein glycosylation and implications for genes, environment and disease.
• Repurposing of natural products with epigenetic functions through an integrated –omics analysis
Epigenetics in drug discovery have recently drawn a lot of attention and there are increasing number of applications as reflected in the growing number publications and citations on this subject. This is because epigenetic dysfunction is widely implicated in several human diseases, including cancer, neurodegenerative and parasitic diseases. Epigenetic broadly involves covalent changes on the building blocks of chromatins called nucleosomes. The reactions involved include methylation, acetylation, phosphorylation, ubiquination and reverse reactions of those. Natural products are regaining attention as sources of lead compounds that can be used as a starting point of drug or epigenetic probe discovery. Natural products have documented large structural diversity with unique and complex scaffolds with promising activity and selectivity profile with epigenetic targets.
In this special collection of articles, we focus on natural products and natural product mimics and their derivatives that play modulatory or inhibitory roles in the epigenome. While current reviews mostly lay emphasis on naturally occurring epigenetic inhibitors and modulators of human disease targets, this series also looks at the epigenome of microbes and plants, which host the biosynthesis processes for making secondary metabolites.
Submissions (Editorials, Reviews, Concepts, Notes, Perspectives, Original Research, Book Reviews, etc.) are welcome in (but not limited to) the following topics:
• Natural remedies and pharmacogenomics of age-related and neurodegenerative disorders
• Implications of compounds of natural origin in disease-associated epigenetic mechanisms.
• Chemoinformatics exploration of the chemical space and target space of natural products with epigenetic functions.
• Bromodomain inhibitors of natural origin.
• A (re)classification of sirtuins and histone deacetylases based on current knowledge.
• Epigenetics in plant and marine life forms, fungal and microbial biosynthesis.
• Epigenetics and network pharmacology associated with treatment with natural remedies.
• Protein glycosylation and implications for genes, environment and disease.
• Repurposing of natural products with epigenetic functions through an integrated –omics analysis
